Literature DB >> 18823203

Selective attention and control of action: comparative psychology of an artificial, evolved agent and people.

Robert Ward1, Ronnie Ward.   

Abstract

This study examined the selective attention abilities of a simple, artificial, evolved agent and considered implications of the agent's performance for theories of selective attention and action. The agent processed two targets in continuous time, catching one and then the other. This task required many cognitive operations, including prioritizing the first target (T1) over the second (T2); selectively focusing responses on T1, while preventing T2 from interfering with responses; creating a memory for the unselected T2 item, so that it could be efficiently processed later; and reallocating processing towards T2 after catching T1. The evolved agent demonstrated all these abilities. Analysis shows that the agent used reactive inhibition to selectively focus behavior. That is, the more salient T2, the more strongly responses towards T2 were inhibited and the slower the agent was to subsequently reallocate processing towards T2. Reactive inhibition was also suggested in two experiments with people, performing a virtually identical catch task. The presence of reactive inhibition in the simple agent and in people suggests that it is an important mechanism for selective processing.

Entities:  

Mesh:

Year:  2008        PMID: 18823203     DOI: 10.1037/0096-1523.34.5.1165

Source DB:  PubMed          Journal:  J Exp Psychol Hum Percept Perform        ISSN: 0096-1523            Impact factor:   3.332


  2 in total

1.  Good vibrations switch attention: an affective function for network oscillations in evolutionary simulations.

Authors:  Bram T Heerebout; R Hans Phaf
Journal:  Cogn Affect Behav Neurosci       Date:  2010-05       Impact factor: 3.282

2.  Evidence inhibition responds reactively to the salience of distracting information during focused attention.

Authors:  Natalie Wyatt; Liana Machado
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.